All week long, we’ve focused on metastatic breast cancer–what it’s like to live with it and how we need to come together to strengthen the breast cancer community. Today, we’re focusing on where we are in understanding MBC and how YOU can support the many organizations and researchers working to expand treatment options and find a way to end MBC all together.
Help Keep Me In The Picture – YSC is proud to be part of the Metastatic Breast Cancer Alliance. Sign their petition to ensure the CDC and SEER have the funding to collect accurate statistics for those with metastatic breast cancer.
A Story Half Told – An initiative by Pfizer in partnership with advocates, patients and healthcare professionals that aims to elevate public understanding of metastatic breast cancer, dispel misperceptions, combat stigma and expand the breast cancer conversation to be more inclusive of metastatic breast cancer.
Metastatic Research Opportunities
Metastatic Breast Cancer Project – Join this nationwide movement of patients, doctors and scientists by sharing your tumor samples so that we can speed the development of future therapies.
Metastatic Trial Search – YSC is proud to partner on this first-ever clinical trial search engine for those with metastatic breast cancer.
The METRIC Study – Recruiting patients with metastatic triple negative breast cancer which over expresses the gpNMB protein to test the effectiveness of a new antibody drug conjugate (a targeted means of giving chemo) called CDX-011.
Researcher at Towson University Department of Family Studies is looking for a few women, ages 18-40, diagnosed with metastatic breast cancer, who live anywhere in the US and would be willing to participate in a phone or in-person interview. This pilot study is looking at the social support needs of young women with metastatic breast cancer and will be the basis for a larger, future, study. If interested, please contact Professor Ginter at email@example.com.
Metastatic Research Articles
How a small implanted device could help limit metastatic breast cancer – A study team from University of Michigan found that a “scaffold” made of biodegradable FDA-approved materials, implanted under the skin, captured metastatic breast cancer cells and slowed disease progression in mice. Mice with the scaffold implanted lived longer. It is thought that the scaffold may enable earlier detection of metastatic disease and may improve outcomes because cancer cells “caught” can be examined to determine best treatment. The research still needs to be proven in humans.
70-Gene Signature Could Help Early-Stage Breast Cancer Patients Avoid Chemotherapy – A recent study in the New England Journal of Medicine examined the use of the MammaPrint 70-gene signature test in patients at high clinical risk of breast cancer recurrence but low genomic risk. These patients were randomized to chemo versus no chemo and no difference was found in distant metastasis. If the test was used in all women at high clinical risk, it was estimated that 46% could safely avoid chemo.